We fight to improve the lives
of everyone affected by epilepsy

Brivaracetam accepted for use in children 4 years and older in Scotland and Wales

7 Jan 2019

The epilepsy medicine Briviact (brivaracetam) will now be available within NHS Scotland and NHS Wales for children over 4 years old for focal-onset seizures. This will be used as an add-on medicine taken alongside the person’s other medicines.

Brivaracetam is already available for use in children 4 years and older across Europe, authorised by the European Medicines Agency in July 2018.

The Scottish Medicines Consortium accepted expanding the use of this medicine in Scotland on 10 December 2018. The All Wales Medicines Strategy Group also extended the licence for the medicine in December to include children over 4 years old in Wales. UCB, the manufacturer of Briviact, said that this decision will give children with uncontrolled epilepsy another option.

Laura Byram, ecosystem head of neurology at UCB called epilepsy an area of unmet need. She added that “more [epilepsy medicines] need to be made available to children in order to maximise the potential of achieving seizure control.”

The company explained that the safety and effectiveness of brivaracetam has been studied in adults and additional safety studies in children over 4. UCB added that focal-onset seizures in children are similar to those in adults and epilepsy medicines affect them in a similar way. The dose is adjusted for children.

The possible side-effects from this medicine in children are similar to those seen in adults. These include drowsiness, dizziness, headaches and tiredness. However, an additional side-effect reported in children was restlessness, called psychomotor hyperactivity.

 

You may also be interested in...

UK medicines regulator launches 2018 campaign to encourage reporting of medicine side-effects

This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is running a campaign to raise awareness of reporting medicine side-effects.

There are no comments yet. Be the first to comment...

Question about your epilepsy?

Your question will be sent to our helpline advisors.

Have a comment about this page?

All comments are reviewed by a moderator before publishing. Comments will be edited or deleted if they are offensive, libellous, slanderous, abusive, commercial or irrelevant.

We ask for your email when you make a comment through this website. This means that we can let you know directly that we have replied to you. By making a comment through the website, you allow us to use the comment in our publicity without using your name. If we would like to use your name, we will email you to get your permission.

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
13 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.